These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

531 related items for PubMed ID: 9886493

  • 21. c-Myc does not require max for transcriptional activity in PC-12 cells.
    Ribon V, Leff T, Saltiel AR.
    Mol Cell Neurosci; 1994 Jun; 5(3):277-82. PubMed ID: 8087425
    [Abstract] [Full Text] [Related]

  • 22. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation.
    Lüscher B, Larsson LG.
    Oncogene; 1999 May 13; 18(19):2955-66. PubMed ID: 10378692
    [Abstract] [Full Text] [Related]

  • 23. c-Myc inactivation by mutant Max alters growth and morphology of NCI-H-630 colon cancer cells.
    Borrè A, Cultraro CM, Segal S.
    J Cell Physiol; 1996 Oct 13; 169(1):200-8. PubMed ID: 8841436
    [Abstract] [Full Text] [Related]

  • 24. Sequential expression of the MAD family of transcriptional repressors during differentiation and development.
    Quéva C, Hurlin PJ, Foley KP, Eisenman RN.
    Oncogene; 1998 Feb 26; 16(8):967-77. PubMed ID: 9519870
    [Abstract] [Full Text] [Related]

  • 25. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
    Wang Z, Ge L, Wang M, Carr BI.
    J Cell Physiol; 2006 Jul 26; 208(1):133-40. PubMed ID: 16596619
    [Abstract] [Full Text] [Related]

  • 26. Retinoblastoma protein is rapidly dephosphorylated by elevated cyclic adenosine monophosphate levels in human B-lymphoid cells.
    Christoffersen J, Smeland EB, Stokke T, Taskén K, Andersson KB, Blomhoff HK.
    Cancer Res; 1994 Apr 15; 54(8):2245-50. PubMed ID: 8174134
    [Abstract] [Full Text] [Related]

  • 27. Regulation of c-Myc and Max in megakaryocytic and monocytic-macrophagic differentiation of K562 cells induced by protein kinase C modifiers: c-Myc is down-regulated but does not inhibit differentiation.
    Lerga A, Crespo P, Berciano M, Delgado MD, Cañelles M, Calés C, Richard C, Ceballos E, Gutierrez P, Ajenjo N, Gutkind S, León J.
    Cell Growth Differ; 1999 Sep 15; 10(9):639-54. PubMed ID: 10511314
    [Abstract] [Full Text] [Related]

  • 28. Evolutionary relationships and functional conservation among vertebrate Max-associated proteins: the zebra fish homolog of Mxi1.
    Schreiber-Agus N, Chin L, Chen K, Torres R, Thomson CT, Sacchettini JC, DePinho RA.
    Oncogene; 1994 Nov 15; 9(11):3167-77. PubMed ID: 7936639
    [Abstract] [Full Text] [Related]

  • 29. Regulation of human ornithine decarboxylase expression following prolonged quiescence: role for the c-Myc/Max protein complex.
    Peña A, Wu S, Hickok NJ, Soprano DR, Soprano KJ.
    J Cell Physiol; 1995 Feb 15; 162(2):234-45. PubMed ID: 7822433
    [Abstract] [Full Text] [Related]

  • 30. Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1.
    Rao G, Alland L, Guida P, Schreiber-Agus N, Chen K, Chin L, Rochelle JM, Seldin MF, Skoultchi AI, DePinho RA.
    Oncogene; 1996 Mar 07; 12(5):1165-72. PubMed ID: 8649810
    [Abstract] [Full Text] [Related]

  • 31. Transfected wild-type and mutant max regulate cell growth and differentiation of murine erythroleukemia cells.
    Cogliati T, Dunn BK, Bar-Ner M, Cultraro CM, Segal S.
    Oncogene; 1993 May 07; 8(5):1263-8. PubMed ID: 8479748
    [Abstract] [Full Text] [Related]

  • 32. Expression of Mad1 protein inhibits proliferation of cancer cells and inversely correlated with Myc protein expression in primary gastric cancer.
    Han S, Park K, Kim HY, Lee MS, Kim HJ, Kim YD.
    Oncol Rep; 1999 May 07; 6(3):569-74. PubMed ID: 10203593
    [Abstract] [Full Text] [Related]

  • 33. The effect of cyclic-AMP on the regulation of c-myc expression in T lymphoma cells.
    Albert DA.
    J Clin Invest; 1995 Apr 07; 95(4):1490-6. PubMed ID: 7706453
    [Abstract] [Full Text] [Related]

  • 34. The Mad1 transcription factor is a novel target of activin and TGF-beta action in keratinocytes: possible role of Mad1 in wound repair and psoriasis.
    Werner S, Beer HD, Mauch C, Lüscher B, Werner S.
    Oncogene; 2001 Nov 08; 20(51):7494-504. PubMed ID: 11709721
    [Abstract] [Full Text] [Related]

  • 35. A Myb dependent pathway maintains Friend murine erythroleukemia cells in an immature and proliferating state.
    Chen J, Kremer CS, Bender TP.
    Oncogene; 2002 Mar 14; 21(12):1859-69. PubMed ID: 11896618
    [Abstract] [Full Text] [Related]

  • 36. The NMR solution structure of a mutant of the Max b/HLH/LZ free of DNA: insights into the specific and reversible DNA binding mechanism of dimeric transcription factors.
    Sauvé S, Tremblay L, Lavigne P.
    J Mol Biol; 2004 Sep 17; 342(3):813-32. PubMed ID: 15342239
    [Abstract] [Full Text] [Related]

  • 37. New Myc-interacting proteins: a second Myc network emerges.
    Sakamuro D, Prendergast GC.
    Oncogene; 1999 May 13; 18(19):2942-54. PubMed ID: 10378691
    [Abstract] [Full Text] [Related]

  • 38. Gamma interferon induces expression of Mad1 gene in macrophage, which inhibits colony-stimulating factor-1-dependent mitogenesis.
    Dey A, Kim L, Li W.
    J Cell Biochem; 1999 Feb 01; 72(2):232-41. PubMed ID: 10022505
    [Abstract] [Full Text] [Related]

  • 39. Mnt transcriptional repressor is functionally regulated during cell cycle progression.
    Popov N, Wahlström T, Hurlin PJ, Henriksson M.
    Oncogene; 2005 Dec 15; 24(56):8326-37. PubMed ID: 16103876
    [Abstract] [Full Text] [Related]

  • 40. Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis.
    Hurlin PJ, Foley KP, Ayer DE, Eisenman RN, Hanahan D, Arbeit JM.
    Oncogene; 1995 Dec 21; 11(12):2487-501. PubMed ID: 8545105
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.